CN104458710A - 肿瘤早期高通量电化学发光检测方法的构建 - Google Patents
肿瘤早期高通量电化学发光检测方法的构建 Download PDFInfo
- Publication number
- CN104458710A CN104458710A CN201410744007.4A CN201410744007A CN104458710A CN 104458710 A CN104458710 A CN 104458710A CN 201410744007 A CN201410744007 A CN 201410744007A CN 104458710 A CN104458710 A CN 104458710A
- Authority
- CN
- China
- Prior art keywords
- electrochemical luminescence
- detection method
- complex
- electrochemiluminescence
- iridium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000000504 luminescence detection Methods 0.000 title claims description 8
- 238000010276 construction Methods 0.000 title description 3
- 239000000523 sample Substances 0.000 claims abstract description 25
- 239000010931 gold Substances 0.000 claims abstract description 23
- 229910052741 iridium Inorganic materials 0.000 claims abstract description 23
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000004020 luminiscence type Methods 0.000 claims abstract description 18
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052737 gold Inorganic materials 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 9
- 238000005516 engineering process Methods 0.000 claims abstract description 9
- 238000011161 development Methods 0.000 claims abstract description 8
- 239000000427 antigen Substances 0.000 claims abstract description 7
- 102000036639 antigens Human genes 0.000 claims abstract description 7
- 108091007433 antigens Proteins 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 15
- 229910052710 silicon Inorganic materials 0.000 claims description 13
- 239000010703 silicon Substances 0.000 claims description 13
- 230000004907 flux Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- 238000003745 diagnosis Methods 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000012327 Ruthenium complex Substances 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 5
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 239000002070 nanowire Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 238000004070 electrodeposition Methods 0.000 claims 2
- 239000004020 conductor Substances 0.000 claims 1
- 238000010189 synthetic method Methods 0.000 claims 1
- 238000012216 screening Methods 0.000 abstract description 6
- 230000003321 amplification Effects 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 239000000439 tumor marker Substances 0.000 abstract 3
- 239000002105 nanoparticle Substances 0.000 abstract 2
- 229910021426 porous silicon Inorganic materials 0.000 abstract 2
- 230000027756 respiratory electron transport chain Effects 0.000 abstract 2
- 230000009545 invasion Effects 0.000 abstract 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- -1 bipyridyl ruthenium Chemical compound 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- JVZRCNQLWOELDU-UHFFFAOYSA-N gamma-Phenylpyridine Natural products C1=CC=CC=C1C1=CC=NC=C1 JVZRCNQLWOELDU-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410744007.4A CN104458710B (zh) | 2014-12-09 | 2014-12-09 | 肿瘤早期高通量电化学发光检测方法的构建 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410744007.4A CN104458710B (zh) | 2014-12-09 | 2014-12-09 | 肿瘤早期高通量电化学发光检测方法的构建 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104458710A true CN104458710A (zh) | 2015-03-25 |
CN104458710B CN104458710B (zh) | 2017-11-14 |
Family
ID=52905114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410744007.4A Expired - Fee Related CN104458710B (zh) | 2014-12-09 | 2014-12-09 | 肿瘤早期高通量电化学发光检测方法的构建 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104458710B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105115961A (zh) * | 2015-08-07 | 2015-12-02 | 上海师范大学 | 一种纳米复合材料的电化学发光传感器的制备方法 |
CN106596942A (zh) * | 2016-12-21 | 2017-04-26 | 山东理工大学 | 一种夹心型乙型肝炎病毒标志物免疫传感器的构建方法及应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006041959A2 (en) * | 2004-10-06 | 2006-04-20 | Wellstat Biologics Corporation | Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
US20090111094A1 (en) * | 2005-08-19 | 2009-04-30 | Nanosphere, Inc. | Methods for preparing hybrid substrates comprising DNA and antibodies and uses thereof |
CN102147414A (zh) * | 2010-12-30 | 2011-08-10 | 中国科学院上海微***与信息技术研究所 | 基于纳米探针的微流体芯片检测微量蛋白的方法 |
CN102967706A (zh) * | 2012-11-21 | 2013-03-13 | 济南大学 | 检测肿瘤标志物流动注射化学发光免疫传感器的制备及应用 |
CN103018231A (zh) * | 2012-12-27 | 2013-04-03 | 济南大学 | 一种复合纳米材料纸芯片电化学发光免疫传感器的制备方法及应用 |
CN103245656A (zh) * | 2013-04-25 | 2013-08-14 | 济南大学 | 甲胎蛋白和癌胚抗原电致化学发光传感器的制备及应用 |
-
2014
- 2014-12-09 CN CN201410744007.4A patent/CN104458710B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006041959A2 (en) * | 2004-10-06 | 2006-04-20 | Wellstat Biologics Corporation | Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
US20090111094A1 (en) * | 2005-08-19 | 2009-04-30 | Nanosphere, Inc. | Methods for preparing hybrid substrates comprising DNA and antibodies and uses thereof |
CN102147414A (zh) * | 2010-12-30 | 2011-08-10 | 中国科学院上海微***与信息技术研究所 | 基于纳米探针的微流体芯片检测微量蛋白的方法 |
CN102967706A (zh) * | 2012-11-21 | 2013-03-13 | 济南大学 | 检测肿瘤标志物流动注射化学发光免疫传感器的制备及应用 |
CN103018231A (zh) * | 2012-12-27 | 2013-04-03 | 济南大学 | 一种复合纳米材料纸芯片电化学发光免疫传感器的制备方法及应用 |
CN103245656A (zh) * | 2013-04-25 | 2013-08-14 | 济南大学 | 甲胎蛋白和癌胚抗原电致化学发光传感器的制备及应用 |
Non-Patent Citations (2)
Title |
---|
HONG ZHOU ET AL.: "Enhanced Iridium Complex Electrochemiluminescence Cytosensing and Dynamic Evaluation of Cell-Surface Carbohydrate Expression", 《CHEMISTRY-A EUROPEAN JOURNAL》 * |
康勤书 等: "纳米金修饰的微柱型微流控芯片用于循环肿瘤细胞检测", 《武汉理工大学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105115961A (zh) * | 2015-08-07 | 2015-12-02 | 上海师范大学 | 一种纳米复合材料的电化学发光传感器的制备方法 |
CN105115961B (zh) * | 2015-08-07 | 2018-02-02 | 上海师范大学 | 一种纳米复合材料的电化学发光传感器的制备方法 |
CN106596942A (zh) * | 2016-12-21 | 2017-04-26 | 山东理工大学 | 一种夹心型乙型肝炎病毒标志物免疫传感器的构建方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104458710B (zh) | 2017-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102226779B (zh) | 一种电化学免疫检测方法 | |
Jozghorbani et al. | Determination of carcinoembryonic antigen as a tumor marker using a novel graphene-based label-free electrochemical immunosensor | |
CN103116023B (zh) | 用于检测肿瘤标志物的电化学发光免疫传感器及其制备方法和应用 | |
CN105556307B (zh) | 电化学侧向流动生物测定和生物传感器 | |
CN102967706B (zh) | 检测肿瘤标志物流动注射化学发光免疫传感器的制备及应用 | |
CN106442994B (zh) | 一种基于Ag@Au纳米复合材料的电化学免疫传感器的制备方法及应用 | |
CN109839501B (zh) | 一种测定循环肿瘤细胞的电致化学发光免疫传感器及其制备方法与应用 | |
CN105572356B (zh) | 一种乳腺癌肿瘤标志物免疫传感器的制备方法及应用 | |
CN104655616A (zh) | 用于检测肿瘤标志物muc1的电化学发光适配体传感器的制备方法及其应用 | |
CN105954339B (zh) | 一种基于CeO2@Cu2O/Au@Pt的夹心型免疫传感器的制备方法及应用 | |
CN102226807B (zh) | 基于Au-PB-SiO2复合纳米颗粒的电化学免疫检测方法 | |
CN104880456A (zh) | 一种基于GO/MWCNTs-COOH/Au@CeO2构建的电化学发光免疫传感器的制备方法及应用 | |
Zhang et al. | An ultrasensitive dual-signal aptasensor based on functionalized Sb@ ZIF-67 nanocomposites for simultaneously detect multiple biomarkers | |
CN105606681B (zh) | 一种基于金铜-多壁碳纳米管-二氧化锰构建的生物传感器的制备方法及应用 | |
Valverde et al. | Electrochemical immunoplatform to improve the reliability of breast cancer diagnosis through the simultaneous determination of RANKL and TNF in serum | |
CN105891483B (zh) | 一种基于石墨烯包裹聚苯乙烯复合纳米球的无标记电化学免疫传感器的制备方法 | |
CN109613244A (zh) | 一种Ag@Pt-CuS标记的免疫传感器的制备方法及应用 | |
CN102721813A (zh) | ***特异抗原均相发光免疫分析检测试剂盒及其检测方法 | |
CN108982605A (zh) | 一种基于富铜离子材料标记的内毒素适配体传感器及其检测内毒素的方法 | |
CN106093390B (zh) | 一种PtCu@g‑C3N4/rGO标记的电化学免疫传感器的制备方法及应用 | |
CN105842460A (zh) | 一种基于银杂化硫化铋的电致化学发光免疫传感器的制备方法 | |
Zhang et al. | A facile integrated microfluidic chip based on Chitosan-Gold Nanoparticles-Anchored Three-Dimensional graphene fiber film for monitoring prostate specific antigen | |
Lin et al. | Electrochemical determination of pyrophosphate at nanomolar levels using a gold electrode covered with a cysteine nanofilm and based on competitive coordination of Cu (II) ion to cysteine and pyrophosphate | |
Sharma et al. | PBIS-based system integrated with zinc–silver nanocomposite for the detection of Chikungunya virus | |
Zhang et al. | In Situ Construction of Oriented Pt‐PANI Needle‐Like Nanoarrays‐Based Label‐Free Aptasensor for Ultrafast and Ultrasensitive Recognition of Cardiac Troponin I |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170425 Address after: 276100 Shandong city of Linyi province Tancheng County Li Zhuang Zhen Qing Shan Cun Xi Valley Park - Dr. Applicant after: SHANDONG HAIMENG BIO-CHEM TECHNOLOGY Co.,Ltd. Address before: 276005 Linyi, Lanshan District, Shandong double Ling Road, the middle Applicant before: Linyi University |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171117 Address after: 276005 Linyi, Lanshan District, Shandong double Ling Road, the middle Co-patentee after: SHANDONG HAIMENG BIO-CHEM TECHNOLOGY Co.,Ltd. Patentee after: LINYI University Address before: 276100 Shandong city of Linyi province Tancheng County Li Zhuang Zhen Qing Shan Cun Xi Valley Park - Dr. Patentee before: SHANDONG HAIMENG BIO-CHEM TECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171114 |